Skip to content

MegaGen BeLux: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MegaGen BeLux

BE 0793.466.136
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€33,106
2024 · €8,571-€41,677
Equity
-€24,927
2024 · €8,179-€33,106
Cash
€1,724
2024 · €197+€1,527
Balance sheet total
€100,159
2024 · €66,131+€34,028

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€24,244

    up €24,244 (+36.8%), from €65,926 to €90,170

    of which Trade receivables: +€17,680

  • Deferred charges and accrued income +€8,257

    up €8,257 (+103,211%), from €8 to €8,265

  • Cash +€1,527

    up €1,527 (+775%), from €197 to €1,724

    mainly Accrued charges and deferred income (+€49,851) and Trade debts (+€19,482)

Equity and liabilities
  • Accrued charges and deferred income +€49,851

    up €49,851 (+21,723%), from €229 to €50,081

  • Profit (loss) carried forward -€33,106

    down €33,106 (-1,818%), from -€1,821 to -€34,927

  • Trade debts +€19,482

    up €19,482 (+96.8%), from €20,118 to €39,600

  • Tax, wage and social debts -€6,863

    down €6,863 (-18.2%), from €37,604 to €30,742

    of which Remuneration and social security: -€11,147

  • Other debts +€4,664

    new in 2025: €4,664

Income statement
  • Gross operating margin -€84,966

    down €84,966 (-76.7%), from €110,769 to €25,803

  • Staff costs -€37,065

    down €37,065 (-37.5%), from €98,827 to €61,761

  • Financial income +€8,399

    up €8,399 (+518%), from €1,620 to €10,019

  • Financial charges +€3,043

    up €3,043 (+86.0%), from €3,537 to €6,579

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €8,571
Gross operating margin -€84,966
Staff costs +€37,065
Other operating charges +€375
Financial income +€8,399
Financial charges -€3,043
Taxes +€492
Result 2025 -€33,106
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€1,527
Investment €0
Financing €0
Cash 2024 €197
Net result for the year -€33,106
Receivables within one year -€24,244
Deferred charges and accrued income -€8,257
Trade debts +€19,482
Tax, wage and social debts -€6,863
Other debts +€4,664
Accrued charges and deferred income +€49,851
Cash 2025 €1,724
brings cash intakes cash out
Every line side by side 32 lines
Line Code 2024 2025 Change %
Total assets 20/58 €66,131 €100,159 +€34,028 +51.5%
Current assets 29/58 €66,131 €100,159 +€34,028 +51.5%
Amounts receivable within one year 40/41 €65,926 €90,170 +€24,244 +36.8%
Trade receivables 40 €36,335 €54,014 +€17,680 +48.7%
Other amounts receivable 41 €29,591 €36,156 +€6,564 +22.2%
Cash at bank and in hand 54/58 €197 €1,724 +€1,527 +775%
Deferred charges and accrued income 490/1 €8 €8,265 +€8,257 +103,211%
Total equity and liabilities 10/49 €66,131 €100,159 +€34,028 +51.5%
Equity 10/15 €8,179 -€24,927 -€33,106
Contributions 10/11 €10,000 €10,000 = 0.0%
Profit (loss) carried forward 14 -€1,821 -€34,927 -€33,106 -1,818%
Amounts payable 17/49 €57,952 €125,086 +€67,134 +116%
Amounts payable within one year 42/48 €57,722 €75,005 +€17,283 +29.9%
Trade debts 44 €20,118 €39,600 +€19,482 +96.8%
Suppliers 440/4 €20,118 €39,600 +€19,482 +96.8%
Taxes, remuneration and social security 45 €37,604 €30,742 -€6,863 -18.2%
Taxes 450/3 €13,783 €18,067 +€4,284 +31.1%
Remuneration and social security 454/9 €23,821 €12,674 -€11,147 -46.8%
Other amounts payable 47/48 - €4,664 +€4,664
Accrued charges and deferred income 492/3 €229 €50,081 +€49,851 +21,723%
Remuneration, social security and pensions 62 €98,827 €61,761 -€37,065 -37.5%
Other operating charges 640/8 €775 €400 -€375 -48.4%
Gross operating margin 9900 €110,769 €25,803 -€84,966 -76.7%
Operating profit (loss) 9901 €11,168 -€36,358 -€47,526
Financial income 75/76B €1,620 €10,019 +€8,399 +518%
Recurring financial income 75 €1,620 €10,019 +€8,399 +518%
Financial charges 65/66B €3,537 €6,579 +€3,043 +86.0%
Recurring financial charges 65 €3,537 €6,579 +€3,043 +86.0%
Profit (loss) for the period before taxes 9903 €9,251 -€32,918 -€42,169
Income taxes 67/77 €680 €188 -€492 -72.3%
Profit (loss) for the period 9904 €8,571 -€33,106 -€41,677
Profit (loss) for the period to be appropriated 9905 €8,571 -€33,106 -€41,677

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.